Executive summary Stroke is the second leading cause of death worldwide. The burden of
disability after a stroke is also large, and is increasing at a faster pace in low-income and …

Deficiency in vitamin D (VitD), a lipid-soluble vitamin and steroid hormone, affects
approximately 24% to 40% of the population of the Western world. In addition to its well …

In 2009, the American Heart Association/American Stroke Association published a
comprehensive scientific statement detailing the nursing care of the patient with an acute …

Objectives: This study aimed to obtain a consensus agreement from an expert panel on the
metaverse for exercise rehabilitation in stroke patients using the Delphi technique. Methods …

Objective: This study aimed to understand the demographics, functional disabilities,
cognitive impairment, and depressive mood among stroke patients and to explore the …

The health burden of ischemic stroke is high and will continue to increase with an aging
population. Recurrent ischemic stroke is increasingly recognized as a major public health …

The ability of immune-modulating biologics to prevent and reverse pathology has
transformed recent clinical practice. Full utility in the neuroinflammation space, however …

The ultimate cause of death for most patients with newly diagnosed chronic lymphocytic
leukaemia (CLL) and its relationship to co‐morbid health conditions is poorly defined. We …

Background: Balance impairment is a common disability in post-stroke survivors, leading to
reduced mobility and increased fall risk. Robotic gait training (RAGT) is largely used, along …

Introduction Short chain fatty acids (SCFA) are gut microbiota-derived metabolites that
contribute to the gut-brain axis and may impact stroke outcomes following gut dysbiosis. We …